The transdermal fentanyl patch Matrifen® eases your pain

The transdermal fentanyl patch Matrifen® from Nycomed provides pain relief for patients with both chronic low back pain and cancer pain.

The transdermal fentanyl patch Matrifen® is constructed in an way, that realeses fentanyl in a steady flow to provide relief for patients with severe chronic pain.

>> Information on the transdermal fentanyl patch Matrifen®

Fentanyl belongs to the group of opioids, and transdermal fentanyl has been shown to have fewer side effects compared to morphine tablets and other oral formulations of opiod analgesics.

The transdermal fentanyl patch is a 72 hour fentanyl treatment for patients with severe pain. The fentanyl drug load is less than in other products, adding to a high degree of safety and low environmental burden.

About Nycomed
Nycomed is a young company with a long history. Founded in 1874 in Norway by Morten Nyegaard, the company gradually began to expand into Europe, forming a strong position initially in the Nordic countries.

The modern story really begins in 1999, when Nycomed was established as a European company with a focus on sourcing and developing new pharmaceutical products. With this in place, the pace of this market expansion increased and the company now operates throughout Europe.

Transdermal fentanyl therapy | Respiratory depression | Membrane controlled release